Skip to main
AVNT
AVNT logo

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp has demonstrated robust performance, with organic sales increasing by 5%, supported significantly by its healthcare segment, which reported double-digit growth for six consecutive quarters, culminating in a 14% year-over-year increase in the first half of 2025. Additionally, four out of nine end markets, contributing to 40% of Avient's sales, are on a growth trajectory this year, while total organic sales are projected to rise by approximately 2% in 2025. Despite anticipated challenges in the consumer end market for the second half of 2025, the overall diversification in Avient’s product portfolio across various industries positions the company favorably for sustained revenue growth.

Bears say

Avient Corp has experienced a decline in organic sales, posting a decrease of approximately 2% in the first quarter of 2024, with subsequent growth in the following quarters failing to compensate for this initial drop, raising concerns about overall revenue stability. The company faces weakening demand in the chemicals sector, with anticipated downside risks to volume in the second half of 2025, which could further impact financial performance. Despite a declining dollar potentially providing some support, the fundamentals indicate significant challenges ahead for Avient's revenue and market position.

Avient Corp (AVNT) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 6 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $45.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $45.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.